Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Wang K, Bai Y, Chen S, Huang J, Yuan J, Chen W, Yao P, Miao X, Wang Y, Liang Y, Zhang X, He M, Yang H, Guo H, Wei S.
Wang K, et al. Among authors: chen s, chen w.
Cancer Med. 2018 Jun;7(6):2691-2698. doi: 10.1002/cam4.1481. Epub 2018 Apr 25.
Cancer Med. 2018.
PMID: 29696820
Free PMC article.